Kyushu Medical Center

Fukuoka 810-8563

2 studies enrolling now · 6 studies all time

What they study most

COVID-19, Follicular Lymphoma, Intracerebral Hemorrhage, Large B-cell Lymphoma, Rheumatoid Arthritis

Studies at this site

• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel — Available (expanded access)
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• Antihypertensive Treatment of Acute Cerebral Hemorrhage-II — Stopped early